Cite
LncRNA FGD5‐AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR‐223 and regulating the expression of ECT2 and FAT1.
MLA
He, Chen‐Kun, et al. “LncRNA FGD5‐AS1 Enhances the Proliferation and Stemness of Hepatocellular Carcinoma Cells through Targeting MiR‐223 and Regulating the Expression of ECT2 and FAT1.” Hepatology Research, vol. 52, no. 7, July 2022, pp. 614–29. EBSCOhost, https://doi.org/10.1111/hepr.13767.
APA
He, C., Li, Z., Yi, D., Zhu, X., Liu, R., Zhang, D., Cao, Q., & Chen, Y. (2022). LncRNA FGD5‐AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR‐223 and regulating the expression of ECT2 and FAT1. Hepatology Research, 52(7), 614–629. https://doi.org/10.1111/hepr.13767
Chicago
He, Chen‐Kun, Zeng‐Bo Li, Da Yi, Xiang‐Ya Zhu, Rong‐Rong Liu, Dong‐Xin Zhang, Qian Cao, and Yi‐Ping Chen. 2022. “LncRNA FGD5‐AS1 Enhances the Proliferation and Stemness of Hepatocellular Carcinoma Cells through Targeting MiR‐223 and Regulating the Expression of ECT2 and FAT1.” Hepatology Research 52 (7): 614–29. doi:10.1111/hepr.13767.